Merck Organon Investor Day 2021

Merck hosted an investor day presentation on May 3, 2021, featuring Organon ahead of its planned separation from the parent company. The agenda covered Organon's strategic overview, commercial prospects across women's health, biosimilars, and established brands, along with R&D strategy and financial outlook from senior management.